MGXRX Performance — NYLI Equity Allocation Fund, Class R3
Data updated: 2026-09-23
MGXRX returned +9.38% over one year to Jan 2024. The annualised 3-year return is +5.01%. Against its Alternative category average the fund came out ahead over three years but behind over one: $100 invested three years ago grew to $116, against $107 for the category, and to $109 over one year, against $110. Volatility over the past three years was 16.84% a year. In the 12 months to Jul 2026 the fund lost a net $12.4M, and assets reached $502.17M.
MGXRX Growth of $100
What $100 invested in NYLI Equity Allocation Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Alternative category average over the same months.
| Period | MGXRX | Category average |
|---|---|---|
| 1 year (Feb 2023 – Jan 2024) | $109 | $110 |
| 3 years (Feb 2021 – Jan 2024) | $116 | $107 |
| Since data start (Aug 2019 – Jan 2024) | $142 | $120 |
MGXRX Trailing Returns
Total returns to Jan 2024, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +9.38% |
| 3 years (annualised) | +5.01% |
MGXRX Annual Returns
Calendar-year total returns of NYLI Equity Allocation Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2024 (Jan–Jan) | +0.33% |
| 2023 | +16.64% |
| 2022 | −17.79% |
| 2021 | +20.09% |
| 2020 | +15.01% |
| 2019 (Aug–Dec) | +7.04% |
MGXRX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | +0.3% | — | — | — | — | — | — | — | — | — | — | — |
| 2023 | +7.0% | −2.8% | +0.2% | +0.4% | −1.5% | +5.8% | +3.4% | −2.7% | −4.2% | −3.0% | +8.4% | +5.7% |
| 2022 | −5.6% | −2.2% | +2.0% | −7.9% | +0.5% | −8.4% | +7.8% | −4.1% | −9.2% | +8.2% | +6.7% | −4.9% |
| 2021 | −0.2% | +3.7% | +3.0% | +4.5% | +1.3% | +0.7% | +1.2% | +2.4% | −4.3% | +5.2% | −2.7% | +4.1% |
| 2020 | −1.5% | −7.8% | −14.8% | +11.5% | +5.1% | +2.6% | +4.8% | +6.0% | −3.6% | −2.0% | +12.1% | +4.8% |
| 2019 | — | — | — | — | — | — | — | −2.6% | +1.9% | +2.2% | +2.8% | +2.7% |
MGXRX Risk
Risk measures from monthly returns over Feb 2021 – Jan 2024.
- 3-year volatility (annualised): 16.84%
- 3-year Sharpe ratio: 0.03 (vs 4.5% risk-free rate)
- Best month: +8.36% (Nov 2023)
- Worst month: −9.24% (Sep 2022)
MGXRX Fund Flows
Monthly money in and out of NYLI Equity Allocation Fund, from SEC Form N-PORT.
- 12-month net flow: −$12.4M
- 12-month gross sales (incl. reinvestments): $73.8M
- Sales ÷ redemptions: 0.86×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $2.6M | $6.2M | −$3.5M |
| Jun 2026 | $9.3M | $14.8M | −$5.5M |
| May 2026 | $2.3M | $6.5M | −$4.2M |
| Apr 2026 | $2.4M | $5.2M | −$2.8M |
| Mar 2026 | $2.7M | $6.3M | −$3.5M |
| Feb 2026 | $2.1M | $7.3M | −$5.1M |
| Jan 2026 | $3.5M | $6.2M | −$2.8M |
| Dec 2025 | $31.8M | $8.4M | $23.5M |
| Nov 2025 | $2.5M | $4.3M | −$1.8M |
| Oct 2025 | $3.6M | $6.2M | −$2.7M |
| Sep 2025 | $7.3M | $10.0M | −$2.7M |
| Aug 2025 | $3.6M | $4.8M | −$1.2M |
MGXRX Assets Under Management
Net assets of NYLI Equity Allocation Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $502.17M |
| 2026-04-30 | $495.24M |
| 2026-01-31 | $488.51M |
| 2025-10-31 | $476.09M |
| 2025-07-31 | $454.14M |
| 2025-04-30 | $426.62M |
| 2025-01-31 | $465.07M |
| 2024-10-31 | $460.93M |
| 2024-07-31 | $467.03M |
| 2024-04-30 | $444.74M |
| 2024-01-31 | $444.29M |
| 2023-10-31 | $388.87M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.